ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
58 hedge funds and large institutions have $17.8M invested in Oncternal Therapeutics, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
82% less capital invested
Capital invested by funds: $96.3M → $17.8M (-$78.5M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
58
Holding in Top 10
–
Calls
$1.71M
Puts
$1.77M
Top Buyers
| 1 | +$867K | |
| 2 | +$411K | |
| 3 | +$389K | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$304K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$222K |
Top Sellers
| 1 | -$9.9M | |
| 2 | -$6.39M | |
| 3 | -$3.18M | |
| 4 |
VAM
Visium Asset Management
New York
|
-$3.1M |
| 5 |
JG
Jefferies Group
New York
|
-$1.12M |